Hancock Whitney’s Niagen Bioscience NAGE Stock Holding History

Hancock Whitney’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,528	Closed	-$60K	–	828
2020 Q4	$60K	Buy	+12,528	New	+$61.1K	﹤0.01%	789

Other funds holding NAGE

YRHAM

Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Hancock Whitney's NAGE Position: Q1 2021 in Review

Hancock Whitney sold out of Niagen Bioscience (NAGE) in Q1 2021, closing a stake of 12,528 shares — an estimated $60K sold.

Hancock Whitney first reported a position in NAGE in Q4 2020 and held it in 1 quarter. The position peaked at $60K in Q4 2020. 96 funds tracked by Wall St. Rank hold NAGE as of Q1 2021.

Hancock Whitney reported no remaining Niagen Bioscience position as of Q1 2021 after selling out during the quarter.
Hancock Whitney sold 12,528 Niagen Bioscience shares in Q1 2021, an estimated $60K.
Hancock Whitney first reported a position in Niagen Bioscience in Q4 2020 and held it in 1 quarter.
Hancock Whitney's Niagen Bioscience position peaked at $60K in Q4 2020.
96 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2021.

Based on Hancock Whitney's 13F filing for Q1 2021, filed 14 May 2021.